NEW YORK (Reuters Health) – Adherence to a healthy diet and lifestyle can reduce the lifetime risk of heart failure and the risk of incident hypertension, according to…
NEW YORK (Reuters Health) – Pitavastatin is equivalent to atorvastatin in its ability to reduce coronary plaque volume in patients with acute coronary syndrome (ACS), Japanese researchers have…
NEW YORK (Reuters Health) – For patients with cerebral ischemia, treatment with tissue plasminogen activator (TPA) is known to confer substantial benefit when given within 3 hours of…
NEW YORK (Reuters Health) – Intracoronary nicardipine before elective percutaneous coronary intervention (PCI) does not reduce post-treatment cardiac enzyme leakage in low-risk patients, new research shows. Prior research…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
NEW YORK (Reuters Health) – Information from previous colonoscopies may help identify low-risk polypectomy patients who are unlikely to benefit from intense surveillance, a large prospective cohort study…
NEW YORK (Reuters Health) – New research indicates that survival is similar for smokers and non-smokers who undergo liver transplantation. At least one large insurance company is denying…
NEW YORK (Reuters Health) – When patients with acute coronary syndromes receive non-drug-eluting, carbon-coated stents, the rate of binary angiographic restenosis rate at 6 months is low, according…
NEW YORK (Reuters Health) – A phase III clinical trial comparing treatments for relapsed or refractory mantle cell lymphoma indicates that temsirolimus (Wyeth Pharmaceuticals, Philadelphia) significantly improves progression-free…
